Isabella Bray

3.0k total citations
27 papers, 1.9k citations indexed

About

Isabella Bray is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Isabella Bray has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Neurology and 11 papers in Cancer Research. Recurrent topics in Isabella Bray's work include Neuroblastoma Research and Treatments (17 papers), Signaling Pathways in Disease (10 papers) and MicroRNA in disease regulation (10 papers). Isabella Bray is often cited by papers focused on Neuroblastoma Research and Treatments (17 papers), Signaling Pathways in Disease (10 papers) and MicroRNA in disease regulation (10 papers). Isabella Bray collaborates with scholars based in Ireland, United States and Germany. Isabella Bray's co-authors include Raymond L. Stallings, Kenneth Bryan, Patrick G. Buckley, Niamh H. Foley, Ross C. McKiernan, David C. Henshall, Amanda Tivnan, Karen M. Watters, Sudipto Das and Olga Piskareva and has published in prestigious journals such as Nucleic Acids Research, The Journal of Immunology and PLoS ONE.

In The Last Decade

Isabella Bray

27 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabella Bray Ireland 24 1.5k 1.1k 526 197 149 27 1.9k
Beth Coyle United Kingdom 22 1.1k 0.8× 378 0.3× 368 0.7× 93 0.5× 346 2.3× 59 2.1k
W. Shawn Carbonell United States 15 706 0.5× 388 0.4× 248 0.5× 45 0.2× 361 2.4× 17 1.7k
Marc Valentine United States 19 932 0.6× 134 0.1× 526 1.0× 156 0.8× 211 1.4× 31 1.7k
Timothy R. Gershon United States 20 748 0.5× 259 0.2× 111 0.2× 71 0.4× 175 1.2× 60 1.2k
Fatima Banine United States 15 914 0.6× 179 0.2× 243 0.5× 180 0.9× 136 0.9× 23 1.8k
Yazhong Tao United States 13 689 0.5× 315 0.3× 146 0.3× 62 0.3× 129 0.9× 15 1.2k
Ji-Ung Jung United States 20 702 0.5× 148 0.1× 209 0.4× 102 0.5× 114 0.8× 29 1.3k
Silvestre Oltra Spain 20 626 0.4× 185 0.2× 177 0.3× 478 2.4× 86 0.6× 69 1.1k
Tommaso Pippucci Italy 23 708 0.5× 215 0.2× 99 0.2× 663 3.4× 93 0.6× 71 1.5k
Süleyman Gülsüner United States 21 795 0.5× 223 0.2× 98 0.2× 736 3.7× 296 2.0× 43 1.7k

Countries citing papers authored by Isabella Bray

Since Specialization
Citations

This map shows the geographic impact of Isabella Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabella Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabella Bray more than expected).

Fields of papers citing papers by Isabella Bray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabella Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabella Bray. The network helps show where Isabella Bray may publish in the future.

Co-authorship network of co-authors of Isabella Bray

This figure shows the co-authorship network connecting the top 25 collaborators of Isabella Bray. A scholar is included among the top collaborators of Isabella Bray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabella Bray. Isabella Bray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piskareva, Olga, Harry Harvey, John Nolan, et al.. (2015). The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro. Cancer Letters. 364(2). 142–155. 71 indexed citations
2.
Miller-Delaney, Suzanne F. C., Kenneth Bryan, Sudipto Das, et al.. (2014). Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. Brain. 138(3). 616–631. 124 indexed citations
3.
Harvey, Harry, Olga Piskareva, Laura Creevey, et al.. (2014). Modulation of chemotherapeutic drug resistance in neuroblastoma SK‐N‐AS cells by the neural apoptosis inhibitory protein and mi R ‐520f. International Journal of Cancer. 136(7). 1579–1588. 30 indexed citations
4.
Bonner, Caroline, Sarah J. Bacon, Jasmin Schmid, et al.. (2013). Identification of circulating microRNAs in HNF1A-MODY carriers. Diabetologia. 56(8). 1743–1751. 21 indexed citations
5.
Lynch, Jennifer, Maria Meehan, John Crean, et al.. (2013). Metastasis Suppressor microRNA-335 Targets the Formin Family of Actin Nucleators. PLoS ONE. 8(11). e78428–e78428. 30 indexed citations
6.
Bryan, Kenneth, Marta Terrile, Isabella Bray, et al.. (2013). Discovery and visualization of miRNA–mRNA functional modules within integrated data using bicluster analysis. Nucleic Acids Research. 42(3). e17–e17. 34 indexed citations
7.
Tivnan, Amanda, W. Shannon Orr, Vladimir Gubala, et al.. (2012). Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles. PLoS ONE. 7(5). e38129–e38129. 190 indexed citations
8.
McKiernan, Ross C., Eva M. Jiménez‐Mateos, Isabella Bray, et al.. (2012). Reduced Mature MicroRNA Levels in Association with Dicer Loss in Human Temporal Lobe Epilepsy with Hippocampal Sclerosis. PLoS ONE. 7(5). e35921–e35921. 105 indexed citations
9.
McKiernan, Ross C., Eva M. Jiménez‐Mateos, Takanori Sano, et al.. (2012). Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death. Experimental Neurology. 237(2). 346–354. 72 indexed citations
10.
Ryan, Joseph P., Amanda Tivnan, Joanna Fay, et al.. (2012). MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome. British Journal of Cancer. 107(6). 967–976. 95 indexed citations
11.
Domingo-Fernandéz, Raquel, Karen M. Watters, Olga Piskareva, Raymond L. Stallings, & Isabella Bray. (2012). The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis. Pediatric Surgery International. 29(2). 101–119. 50 indexed citations
12.
Bray, Isabella, Amanda Tivnan, Kenneth Bryan, et al.. (2011). MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma. Cancer Letters. 303(1). 56–64. 71 indexed citations
13.
Stallings, Raymond L., Niamh H. Foley, Isabella Bray, Sudipto Das, & Patrick G. Buckley. (2011). MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation. Seminars in Cancer Biology. 21(4). 283–290. 32 indexed citations
14.
Das, Sudipto, Niamh H. Foley, Kenneth Bryan, et al.. (2010). MicroRNA Mediates DNA Demethylation Events Triggered by Retinoic Acid during Neuroblastoma Cell Differentiation. Cancer Research. 70(20). 7874–7881. 87 indexed citations
15.
Buckley, Patrick G., Leah Alcock, Kenneth Bryan, et al.. (2010). Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q− Neuroblastoma. Clinical Cancer Research. 16(11). 2971–2978. 54 indexed citations
16.
Oglesby, Irene, Isabella Bray, Sanjay H. Chotirmall, et al.. (2010). miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression. The Journal of Immunology. 184(4). 1702–1709. 154 indexed citations
17.
Foley, Niamh H., Isabella Bray, Amanda Tivnan, et al.. (2010). MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2. Molecular Cancer. 9(1). 83–83. 125 indexed citations
18.
Stallings, Raymond L., Niamh H. Foley, Kenneth Bryan, Patrick G. Buckley, & Isabella Bray. (2010). Therapeutic targeting of miRNAs in neuroblastoma. Expert Opinion on Therapeutic Targets. 14(9). 951–962. 33 indexed citations
19.
Buckley, Patrick G., Kenneth Bryan, Sudipto Das, et al.. (2009). Global MYCN Transcription Factor Binding Analysis in Neuroblastoma Reveals Association with Distinct E-Box Motifs and Regions of DNA Hypermethylation. PLoS ONE. 4(12). e8154–e8154. 67 indexed citations
20.
Bray, Isabella, Kenneth Bryan, Patrick G. Buckley, et al.. (2009). Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival. PLoS ONE. 4(11). e7850–e7850. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth Coyle Breakdown of academic impact, for papers by W. Shawn Carbonell Breakdown of academic impact, for papers by Marc Valentine Breakdown of academic impact, for papers by Timothy R. Gershon Breakdown of academic impact, for papers by Fatima Banine Breakdown of academic impact, for papers by Yazhong Tao Breakdown of academic impact, for papers by Ji-Ung Jung Breakdown of academic impact, for papers by Silvestre Oltra Breakdown of academic impact, for papers by Tommaso Pippucci Breakdown of academic impact, for papers by Süleyman Gülsüner
Rankless by CCL
2026